About the Authors

Walliyulahi Ajibola

Contributed equally to this work with: Walliyulahi Ajibola, Ildikó Karcagi

Roles Investigation, Methodology, Project administration

Affiliations Synthetic and Systems Biology Unit, Institute of Biochemistry, Biological Research Centre of the Eötvös Lóránd Research Network, Szeged, Hungary, Faculty of Science and Informatics, Doctoral School in Biology, University of Szeged, Szeged, Hungary

Ildikó Karcagi

Contributed equally to this work with: Walliyulahi Ajibola, Ildikó Karcagi

Roles Investigation, Methodology, Project administration

Affiliation Synthetic and Systems Biology Unit, Institute of Biochemistry, Biological Research Centre of the Eötvös Lóránd Research Network, Szeged, Hungary

Gábor Somlyai

Roles Conceptualization, Writing – review & editing

Affiliation HYD LLC for Cancer Research and Drug Development, Budapest, Hungary

Ildikó Somlyai

Roles Conceptualization, Writing – review & editing

Affiliation HYD LLC for Cancer Research and Drug Development, Budapest, Hungary

Tamás Fehér

Roles Funding acquisition, Methodology, Software, Supervision, Visualization, Writing – original draft

feher.tamas@brc.hu[

Affiliation Synthetic and Systems Biology Unit, Institute of Biochemistry, Biological Research Centre of the Eötvös Lóránd Research Network, Szeged, Hungary

Competing Interests

GS and IS are employed by HYD LLC. HYD LLC for Cancer Research and Drug Development is involved in drug registration based on deuterium depletion and in the development of deuterium-depleted nutritional products. The above company is not traded publicly nor does it distribute shares or annuities. This does not alter our adherence to PLOS ONE policies on sharing data and materials.